(The Hill) — Researchers found the combination of Moderna’s mRNA vaccine and Merck’s Keytruda in melanoma patients reduced the risk of death or relapse of…
(The Hill) — Researchers found the combination of Moderna’s mRNA vaccine and Merck’s Keytruda in melanoma patients reduced the risk of death or relapse of…